A61P 3 - Drugs for disorders of the metabolism

Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
12/2006
12/19/2006	US7151183 Processes for preparing amorphous atorvastatin hemi-calcium
12/19/2006	US7151175 Propenecarboxylic acid amidoxime derivatives, a process for the preparation thereof, and pharmaceutical compositions containing the same
12/19/2006	US7151118 N-(6-Methyl-4'-{[3-(4-methylpiperazin-1-yl)propylamino]carbonyl}-1,1'-biphenyl-3-yl)-2-pyrrolidin-1-ylisonicotinamide; enzyme inhibitors for the treatment of certain diseases and conditions; chemical synthesis
12/19/2006	US7151109 Psychological disorders; anxiolytic agents; antidepressants
12/19/2006	US7151101 For prevention/treatment of cancer, inflammatory diseases, autoimmune diseases, destructive bone disorders, proliferative disorders, infectious diseases, viral diseases and neurodegenerative diseases
12/19/2006	US7151098 Glutamate receptor antagonists
12/19/2006	US7150976 Regulation of human serine-threonine protein kinase
12/19/2006	CA2259538C Compounds having antihypertensive, cardioprotective, anti-ischemic and antilipolytic properties
12/19/2006	CA2251623C Buccal delivery system
12/19/2006	CA2214448C Cereal food product high in soluble fiber
12/19/2006	CA2149496C 11,21-bisphenyl-19-norpregnane derivatives
12/19/2006	CA2098167C Foodstuffs and feedstuffs containing a lipase inhibitor
12/17/2006	CA2549443A1 Diet supplements for causing fast weight loss, improving daytime energy, promoting nighttime relaxation and sleep, controlling appetite and/or increasing metabolism
12/14/2006	WO2006133164A2 Anti-trkb monoclonal antibodies and uses thereof
12/14/2006	WO2006132879A2 Soft gel capsules containing polymethoxylated flavones and palm oil tocotrienols
12/14/2006	WO2006132586A1 Use of plant cell membrane for the for the treatment of obesity
12/14/2006	WO2006132548A1 Cell implantation to prevent and/or treat autoimmune disease
12/14/2006	WO2006132442A1 Vitamin d-like compound
12/14/2006	WO2006132440A1 Solid preparation
12/14/2006	WO2006132438A1 1,3-benzothiazinone derivative and use thereof
12/14/2006	WO2006132436A1 Heterocyclic compound
12/14/2006	WO2006132273A1 Composition comprising peptide having suppressive effect on food intake
12/14/2006	WO2006132205A1 Radical scavenger and active oxygen eliminating agent
12/14/2006	WO2006132197A1 HETEROCYCLIC COMPOUND HAVING TYPE I 11β HYDROXYSTEROID DEHYDROGENASE INHIBITORY ACTIVITY
12/14/2006	WO2006132196A1 NOVEL PHARMACEUTICAL COMPRISING β3 AGONIST
12/14/2006	WO2006132189A1 Screening method for neuronal differentiation inducer
12/14/2006	WO2006132091A1 Novel triglyceride reducing agent
12/14/2006	WO2006131807A1 Preparation of 3-amino-4,5-disubstituted-pyrazole derivatives
12/14/2006	WO2006131452A1 SULFONAMIDE DERIVATIVES USEFUL AS LIVER CARNITINE PALMITOYL TRANSFERASE (L-CPTl) INHIBITORS
12/14/2006	WO2006131326A2 Novel use of (-)-epigallocatechin gallate
12/14/2006	WO2006131232A1 Benzothiazol-2-on derivatives as lipase and phospholipase inhibitors
12/14/2006	WO2006131231A1 Azolopyridine-2-on derivatives as lipase and phospholipase inhibitors
12/14/2006	WO2006130901A1 Control of metabolic abnormalities
12/14/2006	WO2006111776A3 Pharmaceutical composition comprising serum obtained from a naive mammal
12/14/2006	WO2006107062A3 Benzimidazole derivative and use as angiotensin ii antagonist
12/14/2006	WO2006105912A3 Peptides that down regulate the activity of plasma membrane transporters including sodium-d-glucose cotransporter sglt1
12/14/2006	WO2006102674A3 Diphenylheterocycle cholesterol absorption inhibitors
12/14/2006	WO2006096565A3 Methods and pharmaceutical compositions for treating type 1 diabetes mellitus and other conditions
12/14/2006	WO2006094246A3 N-arylmethyl benzamide sirtuin modulators
12/14/2006	WO2006086488A3 Substituted thiophene derivatives as glucagon receptor antagonists, preparation and therapeutic uses
12/14/2006	WO2006053766A8 Methods for purifying trans-(-)-δ9-tetrahydrocannabinol and trans-(+)-δ9-tetrahydrocannabinol
12/14/2006	WO2006014787A3 Compositions containing policosanol and b vitamins and their pharmaceutical uses
12/14/2006	US20060282908 Identification of the genetic determinants of the polymorphic CYP3A5 expression
12/14/2006	US20060281905 Crystallization of IGF-1
12/14/2006	US20060281887 (Meth)acrylate copolymer for use as medical carrier
12/14/2006	US20060281795 Benzinidazole Derivative and Use As AII Receptor Antagonist
12/14/2006	US20060281761 Osteoporosis; oral diseases; bone disorders; atherosclerosis; antiarthritic agents; autoimmune disease; cachexia
12/14/2006	US20060281745 Use of pde4 inhibitors for the treatment of diabetes mellitus
12/14/2006	US20060281742 Amines that inhibit a mammalian anandamide transporter, and methods of use thereof
12/14/2006	US20060281719 Oestrogen-17-sulphamates as inhibitors of steroid sulphatase
12/14/2006	US20060281706 New phosphonate ester derivatives of drugs such as antivirals cidofovir, adefovir, tenofovir, azidothymidine (AZT), or bisphosphonates such as alendronate, or anticancers such as cytosine arabinoside; side effect reduction, less toxic; antiviral
12/14/2006	US20060281152 Glycosaminoglycans derived from the K5 polysaccharide having high anticoagulant and antithrombotic activity and process for their preparation
12/14/2006	US20060280794 Solid pharmaceutical preparation
12/14/2006	US20060280749 Targeted killing of a cell utilizing a chimeric polypeptide comprising a cell-specific targeting moiety and a signal transduction pathway factor
12/14/2006	DE102005026809A1 Benzothiazol-2-on-derivate als Inhibitoren von Lipasen und Phospholipasen Benzothiazol-2-one derivatives as inhibitors of lipases, and phospholipases
12/14/2006	DE102005026808A1 Benzooxazol-2-on-derivate als Inhibitoren von Lipasen und Phospholipasen Benzooxazol-2-one derivatives as inhibitors of lipases, and phospholipases
12/14/2006	CA2611483A1 Cell implantation to prevent and/or treat autoimmune disease
12/14/2006	CA2611451A1 Solid preparation
12/14/2006	CA2610771A1 Anti-trkb monoclonal antibodies and uses thereof
12/14/2006	CA2610325A1 Azolopyridine-2-on derivatives as lipase and phospholipase inhibitors
12/14/2006	CA2610172A1 Heterocyclic compound
12/14/2006	CA2609560A1 Benzothiazol-2-on derivatives as lipase and phospholipase inhibitors
12/14/2006	CA2609208A1 Use of plant cell membrane for the treatment of obesity
12/14/2006	CA2600954A1 Compounds and compositions for use in the prevention and treatment of obesity and related syndromes
12/13/2006	EP1731602A1 Pharmaceutical composition for lowering blood sugar level
12/13/2006	EP1731529A1 Calcium ion leakage inhibitors
12/13/2006	EP1731527A1 Glycoside having 4-methylergost-7-en-3-ol skeleton and drug for ameliorating hyperglycemia
12/13/2006	EP1731524A1 Phenol derivative, medicinal composition containing the same, and medicinal use thereof
12/13/2006	EP1731521A1 Adiponectin increasing agent
12/13/2006	EP1731520A1 Pyrrolo[2,3-d]pyrimidine derivatives which are antagonists of adenosine A1, A2A, and A3
12/13/2006	EP1731513A1 Phenoxyacetic acid derivative and medicine containing the same
12/13/2006	EP1731505A1 Alkoxyphenylpropanoic acid derivatives
12/13/2006	EP1731170A1 Therapeutic agent for diabetes containing insulin resistance improving agent
12/13/2006	EP1731168A1 Antibody drug
12/13/2006	EP1731158A1 Drugs, foods and drinks for ameliorating hyperglycemia
12/13/2006	EP1731157A2 Pharmaceutical compositions and uses for androst-5-ene-3 beta,17 beta-diol
12/13/2006	EP1731150A1 Niosome having metal porphyrin complex embedded therein, process for producing the same and drug with the use thereof
12/13/2006	EP1731134A1 Functional powders
12/13/2006	EP1730188A2 Peptide analogues of gip for treatment of diabetes, insulin resistance and obesity
12/13/2006	EP1730152A2 Tetrahydroquinoline derivatives and a process for preparing the same
12/13/2006	EP1730147A1 Substituted 1,4,8-triazaspiro[4,5]decan-2-on compounds for use in the treatment of obesity
12/13/2006	EP1730136A1 N-piperidine derivates as ccr3 modulators
12/13/2006	EP1730122A2 Pyrimidine derivatives and methods of treatment related to the use thereof
12/13/2006	EP1730118A1 Substituted azole derivatives, compositions, and methods of use
12/13/2006	EP1729774A1 Pyrrolidine compounds
12/13/2006	EP1729767A1 Combination of a heterocyclic compound and an antioxidant and use thereof for treating obesity
12/13/2006	EP1729762A2 Combination therapy for weight management
12/13/2006	EP1729757A2 Inhibitors of dipeptidylpeptidase iv for regulating glucose metabolism
12/13/2006	EP1729749A2 Use of renin inhibitors in therapy
12/13/2006	EP1729598A1 Composition; use of a composition and a method for treating obesity
12/13/2006	EP1729597A1 The use of sphingolipids in the treatment and prevention of type 2 diabetes mellitus, insulin resistance and metabolic syndrome
12/13/2006	EP1434790B1 Calcium-influx inhibitory factor and method of isolation thereof
12/13/2006	EP1425014B1 Diaryl cycloalkyl derivatives, method for producing the same and the use thereof as ppar activators
12/13/2006	EP1420788B1 Novel piperidin-2,6-dione bisulphate salts and their use for the treatment of stress-related affective disorders
12/13/2006	EP1385823B1 Guanidino compounds as melanocortin-4 receptor (mc4-r) agonists
12/13/2006	EP1338651B1 Method of screening remedy for diabetes
12/13/2006	EP1333838B1 Compounds comprising a phytosterol and/or phytostanol moiety and ascorbic acid and use thereof as weight regulating agents
12/13/2006	EP1272219B1 New combination of a betablocker and a cholesterol-lowering agent
12/13/2006	EP1268558B1 Derivatives of partially desulphated glycosaminoglycans endowed with antiangiogenic activity and devoid of anticoagulating effect
12/13/2006	EP1261712B1 Proteins named fctrx and nucleic acids encoding same

1 ... 615 616 617 618 619 620 621 622 623 624 625 626 627 628 629 630 631 632 633 634 635 ... 1298